New drug to treat hepatitis C approved by FDA 

December 9, 2013 8:50 PM

173 0

New drug to treat hepatitis C approved by FDA 

Sovaldi, a new potential cure for the liver-destroying hepatitis C virus, is set to hit the market, but at a steep price: The 12-week treatment is priced at $7,000 a week.

U.S. regulators on Friday approved Gilead Sciences Inc's Sovaldi, also known as sofosbuvir, as a potential cure for chronic infection with the liver-destroying hepatitis C virus.

Read more

To category page

Loading...